<DOC>
	<DOCNO>NCT00003574</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Giving radiation therapy different way may kill tumor cell . PURPOSE : Phase II trial study effectiveness radiation therapy treat patient undergo surgical removal progressive recurrent malignant brain tumor .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Progressive Recurrent Malignant Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate safety GliaSite RTS patient progressive recurrent malignant brain tumor undergoing surgical resection . II . Evaluate performance GliaSite RTS patient . OUTLINE : This open label , multicenter study . Patients undergo surgical resection tumor follow surgical placement GliaSite device resection cavity . One 2 week surgery , patient receive brachytherapy consist infusion iodine I-125 . The I-125 solution remove collect 5-7 day later . The device surgically remove within 24 hour . Patients follow 24 hour , 14 day , 1 year post device removal . PROJECTED ACCRUAL : Approximately 20-40 patient accrue study .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignant glioma : Anaplastic astrocytoma Anaplastic oligodendroglioma Glioblastoma multiforme Unifocal disease Progressive recurrent disease follow radiation therapy and/or chemotherapy Must eligible surgical resection tumor mass No unresectable leptomeningeal spread ventricular invasion outside radiation treatment volume No exophytic ventricular tumor Must maximal crosssectional diameter enhance tumor great 2.0 cm great 5.0 cm preoperative MRI Ratio major ax tumor exceed 1.5 No mark edema preoperative MRI CT correct tumor resection PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Greater 3 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No uncontrolled hypertension , angina pectoris , uncontrolled cardiac dysrhythmia Other : Not pregnant nursing Fertile patient must use effective contraception No serious concurrent infection medical illness No prior concurrent malignancy within 5 year except curatively treat carcinoma situ cervix basal cell carcinoma skin PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy Chemotherapy : See Disease Characteristics No concurrent chemotherapy At least 4 week since prior chemotherapy ( 6 week since nitrosoureas ) recover Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 3 month since prior radiotherapy recover Surgery : See Disease Characteristics Other : At least 4 week since prior use medical device No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2000</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>